Clinical trial
Long-term Open-label Trial in Idiopathic Restless Legs Syndrome (RLS)
NCT00498186 · UCB Pharma, Industry · Completed
Key facts
| NCT number | NCT00498186 |
|---|---|
| Title | Long-term Open-label Trial in Idiopathic Restless Legs Syndrome (RLS) |
| Official title | An Open-label Extension Trial to Determine Safety and Tolerability of Long-term Transdermal Application of Rotigotine in Subjects With Idiopathic Restless Legs Syndrome |
| Lead sponsor | UCB Pharma, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Restless Legs Syndrome |
| Intervention type | Drug |
| Interventions | Rotigotine |
| Enrollment | 295 |
| Start date | Jul 1, 2003 |
| Primary completion | Apr 1, 2009 |
| Completion | Apr 1, 2009 |
| First posted | Jul 9, 2007 |
| Last update posted | Oct 2, 2014 |
| Countries | Austria, Germany, Spain |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: